Pensionmark Financial Group, LLC Dia Medica Therapeutics Inc. Transaction History
Pensionmark Financial Group, LLC
- $4.67 Billion
- Q3 2025
A detailed history of Pensionmark Financial Group, LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 34,325 shares of DMAC stock, worth $235,126. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,325
Previous 31,975
7.35%
Holding current value
$235,126
Previous $124,000
89.52%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DMAC
# of Institutions
60Shares Held
6.12MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.54MShares$10.5 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX650KShares$4.45 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA630KShares$4.32 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$4.15 Million0.01% of portfolio
-
Bleichroeder LP New York, NY382KShares$2.62 Million0.47% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $181M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...